SARS-CoV-2 /COVID-19 Admission Screening in a University Hospital Setting
- Conditions
- Covid19SARS-CoV-2
- Registration Number
- NCT04519372
- Lead Sponsor
- University Hospital, Basel, Switzerland
- Brief Summary
The proportion of asymptomatic carriers of SARS-CoV-2 remains elusive, so the potential benefit of systematic screening during the SARS-CoV-2-pandemic is controversial. We investigate the proportion of asymptomatic inpatients who were identified by systematic screening for SARS-CoV-2 upon hospital admission.
Adult patients admitted to the University Hospital Basel from 01.04.-14.06.2020 were routinely tested for SARS-CoV-2 within 72 hours of admission by nasopharyngeal swabs.
Each patient screened during the study period was retrospectively classified symptomatic or asymptomatic for COVID-19 based on medical chart review.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 4099
- The patient population is defined as all adult patients hospitalized in the University Hospital Basel from April 1st, 2020 to June 14th, 2020.
- Outpatients
- Patients with SARS-CoV-2 screening in the outpatient test center
- Patients with a SARS-CoV-2 test more than 72 hours before hospital admission
- Test not performed (for any reason)
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Proportion of SARS-CoV-2 -infected patients 01.04.2020-14.06.2020 We aim to determine the proportion of SARS-CoV-2-infected patients detected by systematic at-admission screening
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
University Hospital Basel, Division of Infectious Diseases and Hospital Epidemiology
🇨🇭Basel, Switzerland